机译:减量FOLFIRINOX方案挽救性治疗吉西他滨抵抗的晚期胰腺癌:一项Ⅱ期研究
Department of Internal Medicine,Institute of Health Sciences,Gyeongsang National University,15 Jinju-daero 816beon-gil,Jinju52727,Republic of Korea;
Divsion of Hematology and Oncology,Department of Internal Medicine,Soonchunhyang University Hospital Cheonan,Cheonan 31151,Republic of Korea;
Divsion of Hematology and Oncology,Department of Internal Medicine,Soonchunhyang University Hospital Cheonan,Cheonan 31151,Republic of Korea;
Divsion of Hematology and Oncology,Department of Internal Medicine,Soonchunhyang University Hospital Cheonan,Cheonan 31151,Republic of Korea;
Department of Internal Medicine,Chung-AngUniversity,College of Medicine,Seoul 06973,Republic of Korea;
Departmentof Internal Medicine,Dankook University Hospital,Cheonan 31116,Republic of Korea;
Department of Hematology-Oncology,Ajou University Hospital,Suwon16499,Republic of Korea;
Department of Hematology-Oncology,Ajou University Hospital,Suwon16499,Republic of Korea;
Department of Internal Medicine,Institute of Health Sciences,Gyeongsang National University,15 Jinju-daero 816beon-gil,Jinju52727,Republic of Korea;
Divsion of Hematology and Oncology,Department of Internal Medicine,Soonchunhyang University Hospital Cheonan,Cheonan 31151,Republic of Korea;
Department of InternalMedicine,Dong-A University Hospital,Busan 49201,Republic of Korea;
Department of Internal Medicine,Kangwon National University School of Medicine,Chuncheon 24289,Republic of Korea;
Divsionof Hematology and Oncology,Department of Internal Medicine,Soonchunhyang University Hospital Seoul,Seoul 04401,Republic of Korea;
Department of Internal Medicine,Ewha Womans University,College of Medicine,Seoul 07985,Republic of Korea;
Departmentof Internal Medicine,Dankook University Hospital,Cheonan 31116,Republic of Korea;
Department of Internal Medicine,Chung-AngUniversity,College of Medicine,Seoul 06973,Republic of Korea;
Division of Hematology and Medical Oncology,Department of Internal Medicine,Korea Cancer Hospital,Seoul 01812,Republic of Korea;
机译:FOLFIRINOX在吉西他滨难治性晚期胰腺癌的挽救性治疗中的II期研究
机译:FOLFIRINOX在吉西他滨难治性晚期胰腺癌的挽救性治疗中的II期研究
机译:多西他赛与吉西他滨加多西他赛治疗局部晚期或转移性乳腺癌:一项随机III期研究[多西他赛单药治疗与吉西他滨联合治疗局部晚期或转移性乳腺癌:一项随机III期研究]
机译:非热血浆和吉西他滨联合治疗对MIA PaCa-luc原位胰腺癌模型的抗肿瘤作用
机译:吉西他滨联合曲贝汀联合治疗胰腺癌的多尺度药效学研究。
机译:FOLFIRINOX在吉西他滨难治性晚期胰腺癌的挽救性治疗中的II期研究
机译:吉西他滨在Folfirinox失败后作为晚期胰腺癌的二线化疗方案:一项回顾性研究
机译:胰腺癌:行动议程。胰腺癌进展评估小组的报告